Advertisement
Legal
Subscribe to Legal

The Lead

FTC Sues Gerber Over Claims on Infant Formula

October 30, 2014 2:02 pm | by ANNE FLAHERTY, Associated Press | News | Comments

Federal regulators announced Thursday they were suing Gerber, the well-known baby food maker, for claiming that its Good Start Gentle formula can prevent or reduce allergies in children.           

How Some Colored Contacts Could Permanently Damage Your Eyes

October 28, 2014 8:53 am | Videos | Comments

The U.S. government is working to seize all colored contacts not approved by the FDA. ...

Pfizer Wins SUTENT® Patent Case

October 23, 2014 10:14 am | News | Comments

Pfizer announced that the U.S. District Court for the District of Delaware upheld its basic...

Study Finds Drugs Still in Recalled Supplements

October 22, 2014 8:58 am | by LINDSEY TANNER, AP Medical Writer | News | Comments

Dietary supplements containing potentially dangerous prescription drug ingredients may still be...

View Sample

FREE Email Newsletter

German Firm Wins Appeal in Spain Thalidomide Case

October 22, 2014 8:13 am | News | Comments

A Spanish court has upheld an appeal by a German pharmaceutical company, ditching a previous ruling that ordered the company to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide.      

Noven Files Patent Infringement Lawsuit Against Actavis

October 17, 2014 8:50 am | News | Comments

The lawsuit was filed as a result of Actavis submitting an Abbreviated New Drug Application to the FDA in which Actavis is seeking approval to market and sell a generic version of Brisdelle® capsules prior to the expiration of the patents.  

Supreme Court Weighs Generic Drug Dispute

October 15, 2014 1:28 pm | by SAM HANANEL, Associated Press | News | Comments

The Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world's best-selling multiple sclerosis treatment.             

Advertisement

Merck Ex-Financial Analyst Facing Insider Trading Charge

October 15, 2014 8:14 am | News | Comments

A former senior finance analyst at Merck & Co. is facing an insider trading charge after authorities said Tuesday that he passed secrets to a friend he met at college that earned $722,000 in illegal profits.       

Sucampo Announces Extension of AMITIZA License and Collaboration Agreement With Takeda

October 14, 2014 9:08 am | News | Comments

Sucampo Pharmaceuticals has announced that it signed an amendment to the existing collaboration and license agreement covering the United States and Canada for AMITIZA with Takeda Pharmaceutical Company.        

Sucampo Settles AMITIZA Patent Litigation

October 10, 2014 8:21 am | News | Comments

Under the terms of the settlement, Sucampo and RTU will grant Par a non-exclusive license to market Par's generic version of lubiprostone 8 mcg soft gelatin capsule and 24 mcg soft gelatin capsule in the U.S. for the indications approved for AMITIZA beginning January 1, 2021, or earlier under certain circumstances.

Pharma Millionaire: I Didn't Force Meds Down Son's Throat

October 8, 2014 3:23 pm | by JENNIFER PELTZ, Associated Press | News | Comments

A pharmaceuticals millionaire charged with killing her developmentally disabled son in a deluxe hotel room told jurors Wednesday that she didn't force drugs down his throat, as prosecutors maintain. Taking the stand in her murder trial to give an account she's long yearned to tell, Gigi Jordan depicted a failed murder-suicide.

Safety Advocates Seek Stronger Warnings on Chantix

October 8, 2014 10:09 am | by MATTHEW PERRONE, AP Health Writer | News | Comments

Public safety advocates are asking the federal government to strengthen warnings on Pfizer's anti-smoking drug Chantix, even as the drugmaker prepares to argue that a bolded warning about psychiatric problems should be removed from its medicine's label.

Advertisement

Analyst: GSK's $490M Fine to Spark Pharma Strategy Shift in Emerging Markets

September 24, 2014 11:21 am | News | Comments

The scandal and its repercussions will be felt deep into Big Pharma’s operations in emerging markets, causing a fundamental shift in product marketing approaches involving physicians.           

For Victims, Johns Hopkins Settlement Marks a Step in Recovery

September 22, 2014 8:26 am | by JULIET LINDERMAN, Associated Press | News | Comments

A judge has finalized a $190 million settlement between Johns Hopkins Hospital and more than 8,000 patients of a gynecologist who used tiny cameras to secretly photograph women and girls during examinations.       

Judge to Hear Objections to Hopkins Settlement

September 19, 2014 8:25 am | by JULIET LINDERMAN, Associated Press | News | Comments

A Baltimore judge was set to hear objections Friday to a preliminary $190 million dollar settlement between Johns Hopkins Hospital System and more than 8,000 patients of a gynecologist who used tiny cameras to secretly photograph women and girls during examinations.

China Fines GSK $492M for Bribery

September 19, 2014 5:47 am | by Joe Mcdonald - AP Business Writer - Associated Press | News | Comments

A former executive of drugmaker GlaxoSmithKline and four Chinese co-defendants have been sentenced to prison in a bribery case but may never have to serve that time. China's official Xinhua News Agency said Briton Mark Reilly and his Chinese co-defendants were given a three-year reprieve at their sentencing Friday.

Doctor Pleads Guilty to Cancer Treatment Fraud

September 17, 2014 8:31 am | by ED WHITE, Associated Press | News | Comments

A Detroit-area cancer doctor accused of putting people through unnecessary treatments and then billing insurers for millions of dollars pleaded guilty to fraud Tuesday, admitting that he knew his patients often didn't need chemotherapy.   

Advertisement

Big Cities Take Aim at Prescription Painkillers

September 16, 2014 2:25 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

Some of the nation's largest cities are ratcheting up their criticism of prescription painkillers, blaming the industry for a wave of addiction and overdoses that have ravaged their communities and busted local budgets.      

NY Files Alzheimer's Drug Lawsuit

September 15, 2014 7:42 pm | by Michael Virtanen - Associated Press - Associated Press | News | Comments

New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year.

Skin Shocks Used at Massachusetts School Draw FDA Scrutiny

September 15, 2014 8:44 am | by JENNIFER C. KERR, Associated Press; LAURAN NEERGAARD, Associated Press | News | Comments

The Food and Drug Administration is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use skin shocks as aversive conditioning for aggressive patients.

Chemical Industry Tries to Shape Regulations

September 12, 2014 3:31 pm | by FREDERIC J. FROMMER, Associated Press | News | Comments

The powerful chemical industry is putting its lobbying muscle behind legislation that would establish standards for chemicals used in products from household goods to cellphones and plastic water bottles — but also make it tougher for states to enact their own regulations.

Feds Say Bayer Colon Supplement Makes Bogus Claims

September 12, 2014 3:23 pm | News | Comments

The Department of Justice filed a court motion against the German conglomerate over its advertisements for Phillips' Colon Health, which claims to prevent diarrhea, constipation, gas and bloating. Federal officials say the company does not have reliable scientific evidence to support those claims.

Pharmacist Pleads Not Guilty in Tainted Steroid Case

September 11, 2014 3:23 pm | by DENISE LAVOIE, AP Legal Affairs Writer | News | Comments

A pharmacist who worked for a Massachusetts company blamed for a nationwide meningitis outbreak that killed 64 people pleaded not guilty to a mail fraud charge as his lawyer said he is concerned he could be made a scapegoat.     

Multimillionaire Pharma Entrepreneur Mom on Trial in Autistic Son's Death in NYC Hotel

September 11, 2014 8:21 am | by JENNIFER PELTZ, Associated Press | News | Comments

A multimillionaire mom killed her autistic 8-year-old son by forcing a toxic cocktail of painkillers and other drugs down his throat with a syringe in a luxury Manhattan hotel room, a prosecutor said as her murder trial opened Wednesday.   

Contraception Suits Continue Against White House

September 10, 2014 8:53 am | Videos | Comments

A new batch of lawsuits challenge the White House’s mandate that requires employers to provide contraception for employees.                      

Body Donation Programs in Three States Scrutinized

September 10, 2014 8:35 am | News | Comments

An FBI official in Detroit confirmed that the bureau is looking at an Oregon research center, and investigators have raided facilities in Michigan and Arizona. Besides confirming the existence of an investigation, authorities have been tight-lipped about what they are examining and why.

NY Judge Sentences Pharma ex-Trader to Nine Years in Prison

September 9, 2014 8:23 am | by LARRY NEUMEISTER, Associated Press | News | Comments

A former portfolio manager convicted of helping his firm earn more than a quarter-billion dollars illegally through insider trading on a promising Alzheimer's drug trial was sentenced Monday to nine years in prison by a judge who said lengthy incarceration was earned with a staggering fraud that was the biggest of its kind.

FTC Sues AbbVie, Teva Over Generic AndroGel

September 8, 2014 1:59 pm | News | Comments

The FTC says AbbVie and its partner and Besins Healthcare filed baseless patent infringement lawsuits against Teva Pharmaceutical Industries Ltd. and Perrigo Co. to delay the approval and sale of less-expensive generic versions of the drug.  

Hyperion Therapeutics Terminates Diabetes Program - Discovers Serious Misconduct by Andromeda Biotech

September 8, 2014 8:35 am | News | Comments

Hyperion Therapeutics today announced it is terminating development of DiaPep277 for newly diagnosed Type 1 diabetes. The company has uncovered evidence that certain employees of Andromeda Biotech, which Hyperion acquired in June 2014, engaged in serious misconduct, including collusion with a third-party biostatistics firm.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading